Axonal transport rate decreased at the onset of optic neuritis in EAE mice

NeuroImage

Volumn 100, Issue , 2014, Pages 244-253

  Lin, Tsen Hsuan ^a,c   Kim, Joong Hee ^b   Perez Torres, Carlos ^b   Chiang, Chia Wen ^a   Trinkaus, Kathryn ^b   Cross, Anne H ^b   Song, Sheng Kwei ^b  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

Axonal transport; Manganese enhanced MRI; Optic neuritis

Indexed keywords

MANGANESE; TUBULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXONAL INJURY; BIOACCUMULATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE SEVERITY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNOHISTOCHEMISTRY; MICROTUBULE; MOUSE; MULTIPLE SCLEROSIS; NERVE FIBER TRANSPORT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PRIORITY JOURNAL; TRANSPORT KINETICS; VISUAL ACUITY; VISUAL IMPAIRMENT; ANIMAL; C57BL MOUSE; IMAGE ENHANCEMENT; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES;

ANIMALS; AXONAL TRANSPORT; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MANGANESE; MICE; MICE, INBRED C57BL; OPTIC NEURITIS; VISUAL ACUITY;

EID: 84903994766     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2014.06.009     Document Type: Article

References (82)

1. Andrews H.E., Nichols P.P., Bates D., Turnbull D.M. Mitochondrial dysfunction plays a key role in progressive axonal loss in multiple sclerosis. Med. Hypotheses 2005, 64:669-677.
2. Bearer E.L., Falzone T.L., Zhang X., Biris O., Rasin A., Jacobs R.E. Role of neuronal activity and kinesin on tract tracing by manganese-enhanced MRI (MEMRI). Neuroimage 2007, 37(Suppl. 1):S37-S46.
3. Beck R.W., Cleary P.A., Trobe J.D., Kaufman D.I., Kupersmith M.J., Paty D.W., Brown C.H. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group. N. Engl. J. Med. 1993, 329:1764-1769.
4. Beck R.W., Trobe J.D., Moke P.S., Gal R.L., Xing D.Y., Bhatti M.T., Brodsky M.C., Buckley E.G., Chrousos G.A., Corbett J., Eggenberger E., Goodwin J.A., Katz B., Kaufman D.I., Keltner J.L., Kupersmith M.J., Miller N.R., Nazarian S., Orengo-Nania S., Savino P.J., Shults W.T., Smith C.H., Wall M., Grp O.N.S. High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis. Arch. Ophthalmol. 2003, 121:944-949.
5. Bettelli E., Pagany M., Weiner H.L., Linington C., Sobel R.A., Kuchroo V.K. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 2003, 197:1073-1081.
6. Bitsch A., Schuchardt J., Bunkowski S., Kuhlmann T., Bruck W. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 2000, 123(Pt 6):1174-1183.
7. Blewitt E.S., Pogmore T., Talbot I.C. Double embedding in agar/paraffin wax as an aid to orientation of mucosal biopsies. J. Clin. Pathol. 1982, 35:365.
8. Boretius S., Gadjanski I., Demmer I., Bahr M., Diem R., Michaelis T., Frahm J. MRI of optic neuritis in a rat model. Neuroimage 2008, 41:323-334.
9. Budde M.D., Xie M., Cross A.H., Song S.K. Axial diffusivity is the primary correlate of axonal injury in the experimental autoimmune encephalomyelitis spinal cord: A quantitative pixelwise analysis. J. Neurosci. 2009, 29:2805-2813.
10. Chan K.C., Fu Q.L., Hui E.S., So K.F., Wu E.X. Evaluation of the retina and optic nerve in a rat model of chronic glaucoma using in vivo manganese-enhanced magnetic resonance imaging. Neuroimage 2008, 40:1166-1174.
11. Chan K.C., Li J., Kau P., Zhou I.Y., Cheung M.M., Lau C., Yang J., So K.F., Wu E.X. In vivo retinotopic mapping of superior colliculus using manganese-enhanced magnetic resonance imaging. Neuroimage 2011, 54:389-395.
12. Chen J., Chiang C.W., Zhang H., Song S.K. Cell swelling contributes to thickening of low-dose N-methyl-d-aspartate-induced retinal edema. Invest. Ophthalmol. Vis. Sci. 2012, 53:2777-2785.
13. Chiang C.W., Wang Y., Lin T.H., Cross A.H., Song S.K. Acute visual function impairment in EAE is primarily caused by optic nerve inflammation as assessed by DBSI. Proc. Int. Soc. Magn. Reson. Med. 2012, 20:3085.
14. Compston A., Coles A. Multiple sclerosis. Lancet 2008, 372:1502-1517.
15. Craner M.J., Damarjian T.G., Liu S., Hains B.C., Lo A.C., Black J.A., Newcombe J., Cuzner M.L., Waxman S.G. Sodium channels contribute to microglia/macrophage activation and function in EAE and MS. Glia 2005, 49:220-229.
16. Cross D.J., Flexman J.A., Anzai Y., Maravilla K.R., Minoshima S. Age-related decrease in axonal transport measured by MR imaging in vivo. Neuroimage 2008, 39:915-926.
17. De Vos K.J., Grierson A.J., Ackerley S., Miller C.C. Role of axonal transport in neurodegenerative diseases. Annu. Rev. Neurosci. 2008, 31:151-173.
18. Diem R., Demmer I., Boretius S., Merkler D., Schmelting B., Williams S.K., Sattler M.B., Bahr M., Michaelis T., Frahm J., Bruck W., Fuchs E. Autoimmune optic neuritis in the common marmoset monkey: Comparison of visual evoked potentials with MRI and histopathology. Invest. Ophthalmol. Vis. Sci. 2008, 49:3707-3714.
19. Dutta R., McDonough J., Yin X., Peterson J., Chang A., Torres T., Gudz T., Macklin W.B., Lewis D.A., Fox R.J., Rudick R., Mirnics K., Trapp B.D. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann. Neurol. 2006, 59:478-489.
20. Fairless R., Williams S.K., Hoffmann D.B., Stojic A., Hochmeister S., Schmitz F., Storch M.K., Diem R. Preclinical retinal neurodegeneration in a model of multiple sclerosis. J. Neurosci. 2012, 32:5585-5597.
21. Fang C., Bourdette D., Banker G. Oxidative stress inhibits axonal transport: Implications for neurodegenerative diseases. Mol. Neurodegener. 2012, 7:29.
22. Ferguson B., Matyszak M.K., Esiri M.M., Perry V.H. Axonal damage in acute multiple sclerosis lesions. Brain 1997, 120(Pt 3):393-399.
23. Gadjanski I., Boretius S., Williams S.K., Lingor P., Knoferle J., Sattler M.B., Fairless R., Hochmeister S., Suhs K.W., Michaelis T., Frahm J., Storch M.K., Bahr M., Diem R. Role of n-type voltage-dependent calcium channels in autoimmune optic neuritis. Ann. Neurol. 2009, 66:81-93.
24. Gold R., Linington C., Lassmann H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 2006, 129:1953-1971.
25. Guy J. MRI in experimental inflammatory and mitochondrial optic neuropathies. NMR Biomed. 2008, 21:968-977.
26. Haenold R., Herrmann K.H., Schmidt S., Reichenbach J.R., Schmidt K.F., Lowel S., Witte O.W., Weih F., Kretz A. Magnetic resonance imaging of the mouse visual pathway for in vivo studies of degeneration and regeneration in the CNS. Neuroimage 2012, 59:363-376.
27. Hickman S.J., Toosy A.T., Jones S.J., Altmann D.R., Miszkiel K.A., MacManus D.G., Barker G.J., Plant G.T., Thompson A.J., Miller D.H. A serial MRI study following optic nerve mean area in acute optic neuritis. Brain 2004, 127:2498-2505.
28. Hollenbeck P.J., Saxton W.M. The axonal transport of mitochondria. J. Cell Sci. 2005, 118:5411-5419.
29. Hou Z. A review on MR image intensity inhomogeneity correction. Int. J. Biomed. Imaging 2006, 2006:49515.
30. Jevtovic-Todorovic V., Absalom A.R., Blomgren K., Brambrink A., Crosby G., Culley D.J., Fiskum G., Giffard R.G., Herold K.F., Loepke A.W., Ma D., Orser B.A., Planel E., Slikker W., Soriano S.G., Stratmann G., Vutskits L., Xie Z., Hemmings H.C. Anaesthetic neurotoxicity and neuroplasticity: An expert group report and statement based on the BJA Salzburg Seminar. Br. J. Anaesth. 2013, 111:143-151.
31. Jouhilahti E.M., Peltonen S., Peltonen J. Class III beta-tubulin is a component of the mitotic spindle in multiple cell types. J. Histochem. Cytochem. 2008, 56:1113-1119.
32. Kameyama K., Aono K., Kitamura K. Isoflurane inhibits neuronal Ca2+ channels through enhancement of current inactivation. Br. J. Anaesth. 1999, 82:402-411.
33. Kornek B., Storch M.K., Bauer J., Djamshidian A., Weissert R., Wallstroem E., Stefferl A., Zimprich F., Olsson T., Linington C., Schmidbauer M., Lassmann H. Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain 2001, 124:1114-1124.
34. Leergaard T.B., Bjaalie J.G., Devor A., Wald L.L., Dale A.M. In vivo tracing of major rat brain pathways using manganese-enhanced magnetic resonance imaging and three-dimensional digital atlasing. Neuroimage 2003, 20:1591-1600.
35. Lin F.H., Chen Y.J., Belliveau J.W., Wald L.L. A wavelet-based approximation of surface coil sensitivity profiles for correction of image intensity inhomogeneity and parallel imaging reconstruction. Hum. Brain Mapp. 2003, 19(2):96-111.
36. Lin T.H., Chiang C.W., Trinkaus K., Spees W.M., Sun P., Song S.K. Manganese-enhanced MRI (MEMRI) via topical loading of Mn(2+) significantly impairs mouse visual acuity: A comparison with intravitreal injection. NMR Biomed. 2014, 27:390-398.
37. Linker R.A., Lee D.H., Demir S., Wiese S., Kruse N., Siglienti I., Gerhardt E., Neumann H., Sendtner M., Luhder F., Gold R. Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: Therapeutic implications in a model of multiple sclerosis. Brain 2010, 133:2248-2263.
38. Luo L., Xu H., Li Y., Du Z., Sun X., Ma Z., Hu Y. Manganese-enhanced MRI optic nerve tracking: Effect of intravitreal manganese dose on retinal toxicity. NMR Biomed. 2012, 25:1360-1368.
39. Macaskill A.F., Rinholm J.E., Twelvetrees A.E., Arancibia-Carcamo I.L., Muir J., Fransson A., Aspenstrom P., Attwell D., Kittler J.T. Miro1 is a calcium sensor for glutamate receptor-dependent localization of mitochondria at synapses. Neuron 2009, 61:541-555.
40. MacKenzie-Graham A.J., Rinek G.A., Avedisian A., Morales L.B., Umeda E., Boulat B., Jacobs R.E., Toga A.W., Voskuhl R.R. Estrogen treatment prevents gray matter atrophy in experimental autoimmune encephalomyelitis. J. Neurosci. Res. 2012, 90:1310-1323.
41. Mao P.Z., Reddy P.H. Is multiple sclerosis a mitochondrial disease?. Biochim. Biophys. Acta, Mol. Basis Dis. 2010, 1802:66-79.
42. Mark L.P., Prost R.W., Ulmer J.L., Smith M.M., Daniels D.L., Strottmann J.M., Brown W.D., Hacein-Bey L. Pictorial review of glutamate excitotoxicity: Fundamental concepts for neuroimaging. AJNR Am. J. Neuroradiol. 2001, 22:1813-1824.
43. Massaad C.A., Amin S.K., Hu L., Mei Y., Klann E., Pautler R.G. Mitochondrial superoxide contributes to blood flow and axonal transport deficits in the Tg2576 mouse model of Alzheimer's disease. PLoS One 2010, 5:e10561.
44. Millecamps S., Julien J.P. Axonal transport deficits and neurodegenerative diseases. Nat. Rev. Neurosci. 2013, 14:161-176.
45. Niwa S., Takahashi H., Hirokawa N. beta-Tubulin mutations that cause severe neuropathies disrupt axonal transport. EMBO J. 2013, 32:1352-1364.
46. Ohno N., Kidd G.J., Mahad D., Kiryu-Seo S., Avishai A., Komuro H., Trapp B.D. Myelination and axonal electrical activity modulate the distribution and motility of mitochondria at CNS nodes of Ranvier. J. Neurosci. 2011, 31:7249-7258.
47. Olsen O., Kristoffersen A., Thuen M., Sandvig A., Brekken C., Haraldseth O., Goa P.E. Manganese transport in the rat optic nerve evaluated with spatial- and time-resolved magnetic resonance imaging. J. Magn. Reson. Imaging 2010, 32:551-560.
48. O'Neill J.K., Baker D., Morris M.M., Gschmeissner S.E., Jenkins H.G., Butt A.M., Kirvell S.L., Amor S. Optic neuritis in chronic relapsing experimental allergic encephalomyelitis in Biozzi ABH mice: Demyelination and fast axonal transport changes in disease. J. Neuroimmunol. 1998, 82:210-218.
49. Pascual A.M., Tellez N., Bosca I., Mallada J., Belenguer A., Abellan I., Sempere A.P., Fernandez P., Magraner M.J., Coret F., Sanz M.A., Montalban X., Casanova B. Revision of the risk of secondary leukaemia after mitoxantrone in multiple sclerosis populations is required. Mult. Scler. 2009, 15:1303-1310.
50. Pautler R.G., Koretsky A.P. Tracing odor-induced activation in the olfactory bulbs of mice using manganese-enhanced magnetic resonance imaging. Neuroimage 2002, 16:441-448.
51. Pautler R.G., Silva A.C., Koretsky A.P. In vivo neuronal tract tracing using manganese-enhanced magnetic resonance imaging. Magn. Reson. Med. 1998, 40:740-748.
52. Petratos S., Ozturk E., Azari M.F., Kenny R., Lee J.Y., Magee K.A., Harvey A.R., McDonald C., Taghian K., Moussa L., Mun Aui P., Siatskas C., Litwak S., Fehlings M.G., Strittmatter S.M., Bernard C.C. Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation. Brain 2012, 135:1794-1818.
53. Pitt D., Werner P., Raine C.S. Glutamate excitotoxicity in a model of multiple sclerosis. Nat. Med. 2000, 6:67-70.
54. Redford E.J., Kapoor R., Smith K.J. Nitric oxide donors reversibly block axonal conduction: Demyelinated axons are especially susceptible. Brain 1997, 120(Pt 12):2149-2157.
55. Ridder W.H., Nusinowitz S. The visual evoked potential in the mouse-Origins and response characteristics. Vision Res 2006, 46:902-913.
56. Rintoul G.L., Filiano A.J., Brocard J.B., Kress G.J., Reynolds I.J. Glutamate decreases mitochondrial size and movement in primary forebrain neurons. J Neurosci 2003, 23:7881-7888.
57. Rodriguez M. A function of myelin is to protect axons from subsequent injury: Implications for deficits in multiple sclerosis. Brain 2003, 126:751-752.
58. Roy S., Coffee P., Smith G., Liem R.K., Brady S.T., Black M.M. Neurofilaments are transported rapidly but intermittently in axons: Implications for slow axonal transport. J. Neurosci. 2000, 20:6849-6861.
59. Saleem K.S., Pauls J.M., Augath M., Trinath T., Prause B.A., Hashikawa T., Logothetis N.K. Magnetic resonance imaging of neuronal connections in the macaque monkey. Neuron 2002, 34:685-700.
60. Sally J.D., Sally P.J. Roots to research: A vertical development of mathematical problems 2007, American Mathematical Society, Providence, R.I.
61. Schneider C.A., Rasband W.S., Eliceiri K.W. NIH Image to ImageJ: 25years of image analysis. Nat. Methods 2012, 9:671-675.
62. Shams P.N., Plant G.T. Optic neuritis: A review. Int. MS J. 2009, 16:82-89.
63. Shao H., Huang Z., Sun S.L., Kaplan H.J., Sun D. Myelin/oligodendrocyte glycoprotein-specific T-cells induce severe optic neuritis in the C57BL/6 mouse. Invest. Ophthalmol. Vis. Sci. 2004, 45:4060-4065.
64. Sharma R., Buras E., Terashima T., Serrano F., Massaad C.A., Hu L., Bitner B., Inoue T., Chan L., Pautler R.G. Hyperglycemia induces oxidative stress and impairs axonal transport rates in mice. PLoS One 2010, 5:e13463.
65. Shea T.B., Jung C., Pant H.C. Does neurofilament phosphorylation regulate axonal transport?. Trends Neurosci. 2003, 26:397-400.
66. Silva A.C., Lee J.H., Aoki I., Koretsky A.P. Manganese-enhanced magnetic resonance imaging (MEMRI): Methodological and practical considerations. NMR Biomed. 2004, 17:532-543.
67. Smith K.J., Lassmann H. The role of nitric oxide in multiple sclerosis. Lancet Neurol. 2002, 1:232-241.
68. Smith K.J., Kapoor R., Hall S.M., Davies M. Electrically active axons degenerate when exposed to nitric oxide. Ann. Neurol. 2001, 49:470-476.
69. Smith D.H., Chen X.H., Iwata A., Graham D.I. Amyloid beta accumulation in axons after traumatic brain injury in humans. J. Neurosurg. 2003, 98:1072-1077.
70. Smith K.D., Kallhoff V., Zheng H., Pautler R.G. In vivo axonal transport rates decrease in a mouse model of Alzheimer's disease. Neuroimage 2007, 35:1401-1408.
71. Song S.K., Sun S.W., Ju W.K., Lin S.J., Cross A.H., Neufeld A.H. Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage 2003, 20:1714-1722.
72. Stagi M., Dittrich P.S., Frank N., Iliev A.I., Schwille P., Neumann H. Breakdown of axonal synaptic vesicle precursor transport by microglial nitric oxide. J. Neurosci. 2005, 25:352-362.
73. Stys P.K. General mechanisms of axonal damage and its prevention. J. Neurol. Sci. 2005, 233:3-13.
74. Su K.G., Banker G., Bourdette D., Forte M. Axonal degeneration in multiple sclerosis: The mitochondrial hypothesis. Curr. Neurol. Neurosci. Rep. 2009, 9:411-417.
75. Sun S.W., Liang H.F., Schmidt R.E., Cross A.H., Song S.K. Selective vulnerability of cerebral white matter in a murine model of multiple sclerosis detected using diffusion tensor imaging. Neurobiol. Dis. 2007, 28:30-38.
76. Thuen M., Berry M., Pedersen T.B., Goa P.E., Summerfield M., Haraldseth O., Sandvig A., Brekken C. Manganese-enhanced MRI of the rat visual pathway: Acute neural toxicity, contrast enhancement, axon resolution, axonal transport, and clearance of Mn(2+). J. Magn. Reson. Imaging 2008, 28:855-865.
77. Trapp B.D., Nave K.A. Multiple sclerosis: An immune or neurodegenerative disorder?. Annu. Rev. Neurosci. 2008, 31:247-269.
78. Van der Linden A., Verhoye M., Van Meir V., Tindemans I., Eens M., Absil P., Balthazart J. In vivo manganese-enhanced magnetic resonance imaging reveals connections and functional properties of the songbird vocal control system. Neuroscience 2002, 112:467-474.
79. Wang Y., Wang Q., Haldar J.P., Yeh F.C., Xie M., Sun P., Tu T.W., Trinkaus K., Klein R.S., Cross A.H., Song S.K. Quantification of increased cellularity during inflammatory demyelination. Brain 2011, 134:3590-3601.
80. Wang F.H., Appelkvist P., Klason T., Gissberg O., Bogstedt A., Eliason K., Martinsson S., Briem S., Andersson A., Visser S.A., Ivarsson M., Lindberg M., Agerman K., Sandin J. Decreased axonal transport rates in the Tg2576 APP transgenic mouse: Improvement with the gamma-secretase inhibitor MRK-560 as detected by manganese-enhanced MRI. Eur. J. Neurosci. 2012, 36:3165-3172.
81. Watanabe T., Frahm J., Michaelis T. Functional mapping of neural pathways in rodent brain in vivo using manganese-enhanced three-dimensional magnetic resonance imaging. NMR Biomed. 2004, 17:554-568.
82. Waxman S.G. Axonal conduction and injury in multiple sclerosis: The role of sodium channels. Nat. Rev. Neurosci. 2006, 7:932-941.